The germ cell nuclear factor (GCNF, NR6A1) is a nuclear orphan receptor that functions as a transcriptional repressor and is transiently expressed in mammalian carcinoma cells during retinoic acid (RA) induced neuronal differentiation. During Xenopus laevis development, the spatiotemporal expression pattern of embryonic GCNF (xEmGCNF) suggests a role in anteroposterior specification of the neuroectoderm. Here, we show that RA treatment of Xenopus embryos enhances xEmGCNF expression. Moreover, we present evidence for the relevance of this finding in the context of primary neurogenesis and hindbrain development. During early development of the central nervous system, RA signals promote posterior transformation of the neuroectoderm and increase the number of cells undergoing primary neurogenesis. Our loss-of-function analyses using a xEmGCNF-specific morpholino antisense oligonucleotide indicate that xEmGCNF is required for the effect of RA on primary neurogenesis. This may be caused by transcriptional regulation of the gene encoding the RAdegrading enzyme CYP26, since this gene is derepressed after depletion of xEmGCNF and an antimorph of xEmGCNF directly activates transcription of CYP26, also in absence of protein synthesis. The effect of xEmGCNF knockdown on hindbrain patterning is similar to conditions of reduced RA signaling, which may be caused by a reduction of RARg expression specifically in the presumptive hindbrain. q
Introduction
Neural induction and patterning of the neuroectoderm are the two basic steps of early central nervous system (CNS) development (reviewed by Nieuwkoop, 1999) . Neural induction starts during gastrulation (Gurdon, 1987; Harland and Gerhart, 1997; Smith, 1995) and results in the specification of the neural plate by antagonists of bone morphogenetic protein (BMP), including noggin, chordin, follistatin, cerberus, and xnr3 (see recent reviews by Harland, 2000; Munoz-Sanjuan and Brivanlou, 2002; Sasai and De Robertis, 1997 and references therein) . The anteroposterior specification of the neuroectoderm requires signals including retinoic acid (RA; Durston et al., 1989; Papalopulu et al., 1991; Ruiz i Altaba and Jessell, 1991; Sharpe, 1991; Sive et al., 1990) , fibroblast growth factor (FGF; Isaacs et al., 1992) , cripto (Ciccodicola et al., 1989) , derrière (Sun et al., 1999) and Wnt3A, a member of the Wnt-family (McGrew et al., 1995) , whereas sonic hedgehog (shh; Roelink et al., 1995) and bone morphogenetic protein (BMP; Liem et al., 1995) are known to specify the dorsoventral axis of the CNS.
Several reports support the significant role of RA signaling in anteroposterior patterning of the CNS (Durston et al., 1989; Ruiz i Altaba and Jessell, 1991; Sive et al., 1990) . However, transcriptional regulation of target genes by RA signals is dependent on the concentration of RA, the presence of the nuclear receptors, and transcriptional coregulators (Minucci and Pelicci, 1999) . The availability of the ligand is critical in the regulation of RA signaling and is dependent on the opposing effects of essentially two enzymes, retinaldehyde dehydrogenase 2 (RALDH2; Aldh1a2), which largely controls the biosynthesis of RA by catalyzing the oxidation of retinaldehyde to RA, and CYP26, a cytochrome P450 family member capable of metabolizing RA to 4-OH RA (Maden, 2001; McCaffery and Dräger, 2000) . Therefore, sources of endogenous RA can be localized by studying the expression of RALDH2, which appears to be limited to posterior mesoderm of the Xenopus gastrula and is found in few locations including the posterior lateroventral mesoderm during neurulation (Chen et al., 2001) . As a low molecular weight compound, RA can act at a distance, which is restricted; however, by its limited diffusion and by degradation in cells that contain CYP26, which is expressed in a dynamic pattern in Xenopus ectoderm (Hollemann et al., 1998) . In target cells, RA can activate nuclear retinoic acid receptors (RARs) that function as ligand inducible transcription factors in a heterodimeric complex with a retinoid X receptor partner (RXR; Mangelsdorf and Evans, 1995) . Finally, RARs regulate the transcription of target genes by recruitment of different sets of cofactors depending on whether or not a ligand is bound to the receptor. In the presence of the ligand, the receptor binds to defined response elements (RAREs) on the DNA as heterodimer with RXR, recruits a coactivator complex that acetylates histones and activates transcription of target genes (Glass and Rosenfeld, 2000) . In the absence of ligand, the DNA bound RAR/RXR-heterodimer recruits a corepressor complex capable to deacetylate histones and thus mediates active repression of target genes, a function that seems to be relevant for some aspects of vertebrate head formation (Koide et al., 2001 ).
The germ cell nuclear factor (GCNF) is also a member of the nuclear hormone receptor superfamily first described in the mouse testis (Chen et al., 1994) . Several findings indicate that GCNF functions as a constitutive repressor of its target genes. First, GCNF lacks a conserved motif at the C-terminus, associated in other nuclear hormone receptors with a ligand-dependent transcription activating function (AF2; Yan and Jetten, 2000) . Additionally, it has been shown that the mouse GCNF (mGCNF) can interact with the co-repressors N-Cor and SMRT (Fuhrmann et al., 2001; Yan and Jetten, 2000) . Furthermore, transcriptional repression of reporter genes that contain a GCNF response element (GCRE; Greschik and Schüle, 1998) has also been reported. In agreement with these observations, searches for an activating ligand of GCNF have not yet been successful.
Indeed, binding of mGCNF as part of a high MW complex to a GCRE in the proximal promoter of the mouse Oct4 gene represses its transcription (Fuhrmann et al., 2001 ). The direct negative regulation of the Oct4 gene by mGCNF highlights its important function in the restriction of cell fate of pluripotent embryonic stem cells, embryonic carcinoma cells, and cells of the inner cell mass of mammalian embryos (reviewed by Donovan and Gearhart, 2001) . In GCNF 2 /2 mice, expression of Oct4 is expanded but not completely derepressed (Fuhrmann et al., 2001 ) and these knockout mice display pleiotropic organogenic defects leading to embryonic lethality at day 10.5 post coitum .
During early Xenopus development, the zygotic transcription of the Xenopus embryonic GCNF (xEmGCNF; xNR6A1) starts at the end of gastrulation, reaches its maximal level during neurulation (at stages 16 and 17) and decreases rapidly thereafter (Joos et al., 1996) . At the maximum of zygotic transcription, the expression pattern displays an anteroposterior gradient, with the transcript predominating in the neural folds, with a gap along the midline of the embryo, at the position of the future floor plate, and an elevated level at the midbrain -hindbrain boundary region (MHB; Joos et al., 1996; Song et al., 1999) . Initial studies on interference with xEmGCNF function after overexpression of a dominant-negative form of the protein in Xenopus laevis embryos resulted in a short main body axis, failure of the neural tube to close, and anterior and somitogenic defects, indicating that GCNF is essential for normal development not only of mouse but also of frog embryos (David et al., 1998) . Interestingly, overexpression of xEmGCNF also induced organogenetic defects, predominantly on somitogenesis and tail differentiation (David et al., 1998) , that resembled the effects of late application of exogenous RA (Ruiz i Altaba and Jessell, 1991) .
In this study, we present evidence that illustrate the function of this orphan receptor in the early development of the CNS. We show that retinoic acid treatment of Xenopus embryos enhances xEmGCNF expression. Using ectoderm explants and functional interference in whole embryos, we demonstrate that xEmGCNF function is required to transmit retinoid signals involved in positioning of the MHB, patterning of the hindbrain and primary neurogenesis. We conclude that xEmGCNF is an essential factor required for the regional specification of the neural tube by RA signaling. Furthermore, we present evidence for a direct negative transcriptional regulation of the gene encoding the RA-degrading enzyme CYP26 by xEmGCNF. We conclude that the negative transcriptional regulation of the CYP26 gene is a key step by which xEmGCNF participates in spatiotemporal regulation of RA signaling during patterning of the neural tube and neurogenesis in X. laevis.
Results

RA enhances the expression of xEmGCNF in embryos of X. laevis
Embryonic carcinoma cell lines (PCC7-Mz1, NT-2, P19, F9) that can be induced to differentiate to neurons by treatment with RA, respond to addition of RA by transiently expressing GCNF, in a dose-dependent manner (Bauer et al., 1997; Fuhrmann et al., 2001; Heinzer et al., 1998; Schmitz et al., 1999) . For instance, a transient peak of GCNF mRNA is observed in NT-2 cells shortly after addition of RA, followed by increased GCRE-binding activity that is no longer found in fully differentiated postmitotic cells (Schmitz et al., 1999) .
Using different techniques, we observed an enhanced expression of xEmGCNF in whole embryos of X. laevis that were continuously treated with 10 26 M RA from stage 8 until the stages indicated in Fig. 1 . Whole mount in situ hybridization with an xEmGCNF antisense (as) RNA probe revealed a significant increase of xEmGCNF transcripts in the dorsal region of RA-treated embryos, when compared to non-treated control embryos (Fig. 1A , compare CON and RA columns). Additionally, we also observed an increased xEmGCNF expression in the posterior ventral area of RAtreated embryos, as seen in ventral aspect of stage 17 embryos (Fig. 1A, lower panel) , indicating that RAtreatment also posteriorized the expression pattern of xEmGCNF.
To quantify the increase of xEmGCNF expression after RA treatment detected by means of in situ hybridization, we also analyzed xEmGCNF expression by means of RT-PCR. Densitometric analysis of a typical RT-PCR experiment showed that in the non-treated control embryos xEmGCNF transcription peaks at stage 17 and decreases thereafter (Fig. 1B) , in agreement with our previous results of Northern blot and RNase protection assays (Joos et al., 1996) . In contrast, xEmGCNF expression was about twice as high in the RA-treated embryos at each of the stages analyzed (Fig. 1B) . In addition, RA not only caused an enhanced transcription of xEmGCNF, but also an earlier peak of expression.
Importantly, enhanced xEmGCNF expression after RA treatment was also observed at the protein level by Western blotting (Fig. 1C , lanes 1 -2, 4 -5 and 7 -8). Consistently, the effect caused by RA treatment was inhibited by the RA antagonist citral (Fig. 1C, lanes 3, 6 and 9 ). Altogether, these data suggest that RA signaling in Xenopus embryos positively regulates zygotic expression of xEmGCNF.
xEmGCNF function is required for the effect of RA on primary neurogenesis
The stepwise differentiation of neural precursor cells involves transcription factors such as Xenopus neurogeninrelated-1 (Xngnr1) and neurogenic differentiation factor (NeuroD). The regulatory network leading to neuronal differentiation involves additional factors acting upstream and downstream of Xngnr1 (Ma et al., 1996; Chalmers et al., 2002; Pozzoli et al., 2001 ; for review see Sasai, 1998) .
RA treatment of Xenopus embryos increases the number of cells of the neural plate that undergoes primary neurogenesis without inducing ectopic neurogenesis (Sharpe and Goldstone, 2000) . The transient peak of mGCNF expression in EC cells during their RA-induced differentiation to neurons (Bauer et al., 1997; Heinzer et al., 1998) and the enhancement of xEmGCNF expression in Xenopus embryos after RA treatment (Fig. 1) prompted us to ask whether the effect of RA on primary neurogenesis in Xenopus embryos requires xEmGCNF. To address this question, we have studied the function of xEmGCNF during primary neurogenesis using ectoderm explants of Xenopus embryos and an xEmGCNF-specific morpholino antisense oligonucleotide (MOR; Heasman, 2002; Summerton and Weller, 1997) . Ectoderm explants reduced the complexity of the assay system, since in whole embryos several signaling pathways are likely to cooperate in the posterior specification of the neuroectoderm and, moreover, these could even be partially redundant. In addition, inhibition of translation by gene-specific MOR has been used successfully in Xenopus embryos as an efficient way to obtain loss of target proteins without side effects (Heasman, 2002) . The MOR used in this study was directed to the translational start region of xEmGCNFmRNA and inhibited translation of this mRNA as shown by Western blot (Fig. 2) . Injection of 42 ng of the MOR into each blastomere at the two-cell stage reduced about 90% of the xEmGCNF protein level at neurula stage 17 ( (xOoGCNF), which lacks the region complementary to the MOR (Schohl et al., 2002; Barreto et al., 2003) , thus demonstrating the specificity of the MOR effect.
Fig . 3A shows a schematic representation of the experimental procedure used to investigate the influence of xEmGCNF knockdown on the RA-induced primary neurogenesis. Embryos were injected at the two-cell stage into each blastomere. At stage 8.5, the animal caps of the injected embryos were explanted and incubated until uninjected control embryos reached stage 17. At this stage, the total RNA of the ectoderm explants was extracted and subjected to RT-PCR. The ectoderm was directed to an anterior neural fate by injection of mRNA encoding the BMP antagonist noggin (Nogg, Fig. 3B , lanes 2-5). To achieve posterior specification of the neuroectoderm by (David et al., 1998) . The positions endogenous xEmGCNF (arrow) is indicated at the left. The lowest band (arrowhead) detected by the antiserum is non-related to GCNF and can be used as a loading control.
enhanced RA signaling, the embryos were coinjected with mRNAs encoding Nogg, the retinoid receptors RARa2 and RXRb and the explanted animal caps were treated with 10 27 M RA (Fig. 3B , lanes 3-4). Finally, the expression of several neurogenic and neural markers was compared in the presence and in the absence of xEmGCNF function after injection of STA (Fig. 3B, lanes 1 -3) or MOR (Fig. 3B , lanes 4-6), respectively.
None of the markers for primary neurogenesis analyzed was significantly expressed in ectoderm explants of embryos injected with STA (Fig. 3B, lane 1) . As previously shown by Sharpe and Goldstone (Sharpe and Goldstone, 2000) , the neuralizing activity of noggin alone was not sufficient to induce a significant amount of nerve-specific tubulin (N-tubulin or NST; Lee et al., 1995) transcription (Fig. 3B, upper panel, lane 2) , which required the cooperative action of the proneural signal noggin and the posteriorizing RA signal (Fig. 3B , upper panel, lane 3). In contrast, induction of significant amounts of XDelta-1 Wettstein et al., 1997) , Xngnr1 and NeuroD required only the neuralizing activity of noggin (lane 2), and was further stimulated by RA signaling (lane 3). However, the enhanced expression of all markers for primary neurogenesis caused by RA signaling was reduced after depletion of xEmGCNF protein (Fig. 3B, compare  lanes 3 and 4) , suggesting that (1) RA signaling requires xEmGCNF function and (2) xEmGCNF acts upstream of the signaling cascade responsible for the end differentiation of the prospective neuroectoderm to neural tissue. In contrast, the expression of the pan neural markers N-CAM and Nrp1 was neither affected by RA signaling nor by MOR injection in neuralized animal cap explants (compare lanes 2 -3 to 4 -5), suggesting that xEmGCNF participates in later steps than the initial neural induction caused by antagonists of BMP signaling.
The results obtained in animal cap assays were confirmed in whole embryos, where primary neurogenesis can be analyzed by monitoring the sequential expression of XDelta-1, NST and Islet-1 . Fig. 3C -F shows whole mount in situ hybridization of stage 18 embryos with NST-specific (C-D) or XDelta-1-specific (E -F) asRNA probes. The embryos were injected at the two-cell stage into one hemisphere with 42 ng of the MOR. Additionally, 250 pg mRNA encoding b-galactosidase (b-gal) were coinjected as lineage tracer to identify the injected half (to the right) after colorimetric detection of b-gal activity (in red). In the non-injected half of the embryo, NST and XDelta-1 expression was found in the neural tube and demarcated the position of the differentiating primary neurons. In the MOR-injected half of the Fig. 3 . The effect of RA on primary neurogenesis requires xEmGCNF. (A) Schematic representation of the experimental system. Embryos were injected at the two-cell stage into each blastomere. Animal caps were explanted at stage 8.5 and cultivated until stage 17 equivalent. Total RNA was extracted and semi-quantitative RT-PCR was performed. (B) Knockdown of xEmGCNF abolishes the increasing effect of RA signaling on the expression of primary neurogenesis markers. Injection of 40 pg noggin mRNA directed the ectoderm explants to an anterior neural fate (Nogg, lanes 2-5). Further posterior specification of the neuroectoderm by an enhanced RA signaling (RA, lanes 3-4) was achieved by coinjection of mRNAs encoding the retinoid receptors xRARa2 (250 pg) and xRXRb (250 pg) and treatment of the neuralized explants with 10 27 M RA. In addition, embryos were co-injected with 42 ng of the STA (lanes 1-3) or 42 ng of the MOR (lanes 4-6). Expression of markers of neuronal end differentiation (NST; XDelta-1; Xngnr1 and NeuroD), pan-neural markers (N-CAM and Nrp1) was monitored by RT-PCR using gene-specific primers. Loading control ODC þ RT, negative control ODC 2 RT, whole embryo WE. (C -F) Whole mount in situ hybridization of stage 18 embryos to detect NST (C,D) and XDelta-1 mRNA (E and F) after co-injection of 42 ng of asMOR and 150 pg of b-galactosidase mRNA into one cell at the two-cell stage. b-Galactosidase staining in red identifies the injected hemispheres to the right. Anterior is at the top of each figure. D and F show details of C and E, respectively. embryos, expression of NST and XDelta-1 was weaker, confirming our previous results (Fig. 3B) . Additionally, details of the dorsal region of the embryos show clearly that NST and XDelta-1 expressing cells were dissipated in a broader area compared to the non-injected halfside ( Fig.  3D and F) , as a consequence of defective morphogenetic movements during the formation of the neural tube (Barreto et al., 2003) .
XCYP26 is a target of xEmGCNF
To assess whether the abolishment of the RA effect on primary neurogenesis after MOR injection could be caused by an influence on RA metabolism, we also investigated whether transcription of RALDH2 and CYP26 mRNA was altered using the experimental system described in Fig. 3 . As reported previously (Hollemann et al., 1998; Loudig et al., 2000) enhanced RA signaling increased expression of the RA-degrading enzyme CYP26 (Fig. 4A, compare lanes  1 and 2) . CYP26 expression also increased in anterior neuroectoderm after MOR injection (Fig. 4A, compare  lanes 1 -4) . Interestingly, enhanced RA signaling in combination with xEmGCNF knockdown resulted in a much stronger increase of CYP26 expression (Fig. 4A, lane  3) . Since xEmGCNF is assumed to be a constitutive repressor of transcription, this result could be interpreted as derepression of CYP26 expression after xEmGCNF knockdown. In contrast, RALDH2 expression was detected neither in the anterior nor in the posterior neuroectoderm (Fig. 4A, lanes 1 and 2) , as expected from its expression pattern in the embryo (Chen et al., 2001 ). Yet, depletion of xEmGCNF protein after MOR injection caused an increase of RALDH2 expression in neuralized animal cap explants only in absence of RA signals (Fig. 4A, lane 4) , which are known to suppress RALDH2 expression (Niederreither et al., 1997) . Consequently, xEmGCNF could also act as a repressor of RALDH2 expression in the ectoderm explants. However, this observation could not be substantiated by means of whole mount in situ hybridization of whole embryos (data not shown).
Whole mount in situ hybridization with a CYP26-specific asRNA probe confirmed the results obtained using ectodermal explants (Fig. 4B) . In stage 12 embryos injected in one hemisphere with the MOR (Fig. 4B , upper panels), both the anterior dorsal and the posterior circumblastoporal expression domains of CYP26 were enhanced on the injected side (to the right after b-gal staining in red). After injection of MOR into both blastomeres (Fig. 4B , lower panels) the posterior and the dorsal region of stage 17 embryos expressed higher levels of CYP26 (see brackets in Fig. 4B ) when compared to control embryos injected with the STA (Fig. 4B, middle  panels) . Additionally, the normally elaborate expression pattern of CYP26 in the anterior neural plate (Hollemann et al., 1998) was disturbed without significant increase in the expression level.
To investigate whether CYP26 expression is under direct negative transcriptional control by xEmGCNF, we expressed a fusion protein consisting of mGCNF in combination with the strong activation domain of the herpes virus protein VP16 (VP16-mGCNF), a potential antimorph of GCNF that was previously shown to activate target genes containing a GCRE in their promoter region (Greschik et al., 1999) . As expected, CYP26 transcription was strongly enhanced after ectopic expression of VP16 -mGCNF in ectoderm explants (Fig. 4C, compare lanes 1  and 3) . The higher level of CYP26 expression caused by ectopic VP16 -mGCNF expression was maintained even after inhibition of protein synthesis by treatment of the ectoderm explants with 10 mg/ml of cycloheximide (CHX) for 2 h (Fig. 4C, compare lanes 3 and 4) . This observation suggests that expression of CYP26 is likely under direct negative transcriptional control of xEmGCNF. In contrast, induction of the homeobox gene Xlim1 by VP16 -mGCNF is probably indirect since it was reduced by cycloheximide treatment. Induction of CYP26 by VP16 -mGCNF was much stronger when the explants were cultured until stage 17, and remained also unaffected by 2 h treatment with CHX (data not shown). These results lead us to propose that xEmGCNF knockdown interferes with RA induced posterior transformation of the neuroectoderm by derepressing the RA degrading enzyme CYP26.
Several embryonic carcinoma cell lines (PCC7-Mz1, NT-2, P19, F9) are well-established experimental systems that can be used to investigate neuronal differentiation. We monitored by means of RT-PCR the successive transcriptional activation of genes during RA-triggered neuronal differentiation of human NT2 cells. The transcript of the human Hbox6 gene is a marker for neuronal differentiation (Faiella et al., 1994) and it was first detected 7 days after RA application (Fig. 4D) . Consequently, expression of Oct4, a marker for the pluripotency of EC and ES cells, decreased with progressive neuronal differentiation after addition of RA. As previously shown by Northern blot (Schmitz et al., 1999) , we also observed a transient peak of hGCNF mRNA 2-3 days after RA application. Expression of hCYP26 also increased after RA treatment, confirming that the human CYP26 gene is also a target of RA signals, as reported for the mouse and Xenopus CYP26 gene (Abu-Abed et al., 1998; Hollemann et al., 1998; Loudig et al., 2000) and as suggested by the conserved RARE in its promoter (Loudig et al., 2000) . Importantly, hGCNF expression precedes that of hCYP26, indicating that hGCNF could provide a relay that prevents excessive production of hCYP26 and thus a premature degradation of RA.
xEmGCNF is essential for a correct hindbrain development
The midbrain -hindbrain boundary (MHB) acts as an organizer on the presumptive midbrain and hindbrain, since it produces a series of secreted molecules that control the cell fate of the surrounding cells. The interface between the anterior Otx2-expressing domain and the posterior Gbx2-expressing domain is crucial for the establishment of the MHB, whereas several signaling pathways (including Wnt1, Fgf8, RA and pax2) are important for the maintenance of the MHB (reviewed by Rhinn and Brand, 2001) . Several studies have shown that the subsequent patterning and segmentation of the hindbrain is very sensitive to alterations in RA signaling (recently reviewed by Gavalas, 2002) . Therefore, we investigated the influence of xEmGCNF knockdown on this developmental process by means of whole mount in situ hybridization (Fig. 5A) . Albino embryos were coinjected unilaterally at the two-cell stage with 42 ng of the MOR and 250 pg mRNA encoding b-gal as lineage tracer. The injected side (to the right) was identified by colorimetric detection of b-gal activity (in red). The expression of both Otx2 and Gbx2 was shifted posteriorly on the injected side, causing a repositioning of the MHB, as confirmed by the expression of the MHBmarker En-2 and Pax2, which were also shifted posteriorly after xEmGCNF knockdown (Fig. 5A and data not shown) . Additionally, Otx2 expression was expanded laterally. In the case of Krox-20, which is normally expressed in rhombomeres 3 and 5, injection of the MOR led to loss of the posterior band, whereas the anterior band in rhombomere 3 was shifted posteriorly by about one rhombomere (Fig. 5A ). All these observations suggest an expansion of anterior structures with simultaneous loss of posterior structures, recapitulating the effect of reduced RA signaling on hindbrain patterning.
Since we have previously detected by means of RT-PCR a reduction of RARg2 expression in the anterior part of whole embryos after ectopic expression of a dominantnegative form of GCNF (David et al., 1998) , we analyzed the expression of this RA receptor by means of whole mount in situ hybridization after xEmGCNF knockdown.
Injection of the MOR at the two-cell stage into one or both blastomeres resulted in a specific depletion of RARg transcripts in the region of the presumptive hindbrain between stage 18 and 35 (Fig. 5B, C and data not shown) , whereas the posterior expression domain was almost unaffected. At tailbud stages, the hindbrain-specific decrease of RARg transcription is seen more clearly (Fig. 5C ). This reduction of RARg expression could provide a plausible explanation for the effects observed in this part of the embryo after xEmGCNF knockdown (see Section 3).
Discussion
Requirement of xEmGCNF for the effect of RA on primary neurogenesis
During the phase of anteroposterior patterning of the CNS, xEmGCNF is predominantly expressed in the neuroectoderm. We have shown that RA treatment stimulates xEmGCNF transcription in Xenopus embryos and, on the other hand, that the retinoid-induced posterior transformation of the neuroectoderm requires xEmGCNF. In this report, we present evidences for the significance of this finding within the context of two developmental processes, which are strongly dependent on RA signaling, namely, primary neurogenesis and patterning of the hindbrain.
Whereas neural induction, monitored by the expression of the pan neural markers NCAM and Nrp1, does not require xEmGCNF, several factors involved in primary neurogenesis, x-ngnr1, NeuroD and XDelta-1, are induced by RA in a xEmGCNF-dependent manner. This suggests that xEmGCNF acts upstream of the factors involved in end differentiation of neurons and in the context of RA signaling. Importantly, depletion of xEmGCNF interfered with RA-induced primary neurogenesis not only in animal cap explants but also in whole embryos (Fig. 3B -F and data not shown), where RA signals most likely act in concert with other posteriorizing factors like FGF, wnt3A and derrière (Sun et al., 1999) . In addition to data that we showed here, immunohistological analysis revealed a reduction in the number of Islet-1 positive ventral neurons in Xenopus tadpoles after xEmGCNF knockdown (data not shown).
GCNF and the catabolism of RA signals
We showed that expression of the RA catabolizing enzyme CYP26 was enhanced after xEmGCNF knockdown in animal cap explants, as well as in the dorsal neuroectoderm of whole embryos. Since xEmGCNF is believed to be a constitutive repressor of transcription (Fuhrmann et al., 2001; Yan and Jetten, 2000) , we propose a release of repression of the CYP26 gene as one of the possible reasons for the effects observed after xEmGCNF knockdown in the context of primary neurogenesis.
We also presented evidence for CYP26 being a direct target of GCNF, since CYP26 is activated in ectodermal explants by a VP16 -mGCNF fusion protein even after translational inhibition by cycloheximide treatment. However, the direct regulation of the XCYP26 gene by GCNF awaits final proof by promoter analysis and bandshift assays, since the 5 0 upstream region of the Xenopus CYP26 gene has not been characterized and no candidate of a functional GCRE has been identified in the proximal promoter of the mouse and human CYP26 gene.
It has been previously reported that RA enhances the expression of the CYP26 gene in mouse (Abu-Abed et al., 1998) and X. laevis embryos (Hollemann et al., 1998) ; and the proximal promoter of the mouse, human and zebrafish CYP26 genes contain a canonical RARE (Loudig et al., 2000) . If our argument of a direct negative transcriptional regulation of the CYP26 gene by xEmGCNF is true, the simultaneous induction of CYP26 and of xEmGCNF by RA may appear paradoxical at first glance. However, the kinetics of accumulation of CYP26 and of xEmGCNF may differ. Our results on human NT2 cells show that expression of hGCNF precedes that of hCYP26 during RA-triggered neuronal differentiation. Compared with Xenopus gastrula embryos, the beginning of XCYP26 expression precedes that of xEmGCNF (Chen et al., 2001; Joos et al., 1996) . Yet, between late gastrula and late neurula stages, xEmGCNF expression expands posteriorly indicating a role of xEmGCNF in the definition of the elaborate pattern of the dorsal neural XCYP26 expression domain. We propose that the simultaneous induction of CYP26 and xEmGCNF by RA provides a mechanism by which the spatiotemporal domain of RA signaling is regulated during anteroposterior specification of the neuroectoderm of Xenopus.
Although xEmGCNF overexpression in explants of anterior neuroectoderm resulted in a slightly increased NST transcription, it was not sufficient to induce neural markers normally triggered by RA treatment (data not shown). An explanation for this finding is that one or several cofactors of xEmGCNF need to be co-induced by RA and this cannot be substituted solely by overexpression of xEmGCNF. In agreement with this explanation, in differentiating P19 cells RA induced the formation of a high MW complex that contains mGCNF and binds to a GCRE on the promoter of the oct4 gene (Fuhrmann et al., 2001) , suggesting the existence of cofactors, which are required for xEmGCNF function.
Requirement of xEmGCNF for the hindbrain development
After xEmGCNF knockdown the MHB was shifted posteriorly, expression of the anterior marker Otx2 was expanded laterally and Krox-20 expression in rhombomere 5 was lost, whereas rhombomere 3 was shifted posteriorly. These observations can be interpreted as an expansion of anterior structures with simultaneous loss of posterior structures, similar to the effect of reduced RA signaling on hindbrain patterning. Following this line of interpretation, our results showed that depletion of xEmGCNF protein after MOR injection could affect the RA concentration and the transduction of RA signals, because transcription of CYP26 was elevated in ectoderm explants and in whole embryos and the expression level of RARg, the prevalent RAR isoform throughout Xenopus neurulation (Blumberg et al., 1992; Dreyer, 1991, 1993; Pfeffer and De Robertis, 1994) was reduced specifically in the presumptive hindbrain (Fig. 5B) . In contrast, we did not detect significant alteration in the expression level of RARa and of the co-repressors SMRT and N-Cor by means of RT-PCR after xEmGCNF knockdown (data not shown). Consistent with the results presented here, we reported previously a reduction of RARg2 expression in the anterior part of tailbud embryos after ectopic expression of a dominant-negative form of GCNF (David et al., 1998) . The following scenario could explain our findings: Active repression by ligand-unbound RARa has been reported to be required for the formation of anterior structures (Koide et al., 2001 ). Since xEmGCNF knockdown did not affect RARa expression, an increased CYP26 expression after xEmGCNF knockdown would reduce the RA concentration to critical threshold levels and would generate an overall increase of active repression mediated by ligand-unbound RARa. Because all RAR genes of mammals are known to contain RAREs in their promoter region (Leid et al., 1992 and references therein), active repression mediated by ligand-unbound RARa could provide a plausible explanation for the reduction of RARg transcription after MOR injection. Most likely, the regional reduction of RARg transcription after MOR injection was confined to the area where the expression patterns of RARg and xEmGCNF overlap, arguing for a GCNF-specific mechanism that remains to be elucidated in detail.
Importantly, upregulation of CYP26 in the anterior ectoderm at early stages of development and depletion of RARg in the hindbrain would both, consecutively or in concert, reduce the RA signal in the prospective hindbrain, interfere with its segmentation, and prevent the specification of the posterior rhombomeres r5 and r6, in analogy to the phenotype observed in RALDH 2 /2 mice (Niederreither et al., 2000) . Additionally, the results presented here are also similar to that described for quails subjected to complete dietary vitamin A (retinol) deficiency (Maden et al., 1996 (Maden et al., , 1998 , for chick embryos treated with a pan RA-antagonists (Dupe and Lumsden, 2001) , for mouse embryos after targeted inactivation of both RARa and RARg (Wendling et al., 2001 ) and for Xenopus embryos after overexpression of a constitutive repressing form of RARa (xRARa1 405p ; Blumberg et al., 1997) .
Hindbrain segmentation of vertebrates requires transient RA signaling that proceeds from anterior to posterior in a stage-specific way. Although dynamic gradients of RA have been predicted that form between RALDH2 and CYP26 expressing cells, whose patterns change dramatically in early development of X. laevis (Chen et al., 2001) , the existence of RA gradients has been questioned (Godsave et al., 1998) . In particular, it is currently not understood how application of exogenous RA can rescue the vitamin A deficient phenotype, e.g. of RALDH2 mutants, if a gradient of RA is required (Begemann and Meyer, 2001; Dupe and Lumsden, 2001 ). Therefore, cell intrinsic mechanisms have to be postulated that are able to transmit graded RA signals. We suggest that GCNF, which is transiently induced as an early response to RA, constitutes an essential factor involved in fine-tuning of RA signals. Since CYP26 and xEmGCNF both prevail in the anterior neuroectoderm at late gastrula of Xenopus, where the expression of CYP26 subsequently retracts to specific narrow domains (Holle- Table 1 Gene-specific primer sets and PCR conditions (Joos et al., 1996) , we suggest that a GCNFdependent attenuation of the CYP26 induction by RA provides an important relay mechanism of tissue-intrinsic spatiotemporal control of RA signaling. For both anteroposterior specification of the CNS and primary neurogenesis, xEmGCNF is indispensable, because in its absence CYP26 will be derepressed and cause an RA deficiency leading to depletion of RARg in the hindbrain.
Experimental procedures
Handling of the embryos, microinjection and retinoid treatment
Embryos were obtained as described previously (Medina and Steinbeisser, 2000) and staged according to Nieuwkoop and Faber (1967) . Microinjection was performed in Marc's Modified Ringer's Solution (MMR) at the two-cell stage in the animal pole into both or into one hemisphere using 21 -42 ng per blastomere of a standard control morpholino oligonucleotide (STA; 5 0 -CCTCTTACCTCAGTTA-CAATTTATA-3 0 ) or an xEmGCNF-specific antisense morpholino oligonucleotide (MOR; 5 0 -CATGTGTC-CATCTCATACCAGTGCG-3 0 ). Both morpholino oligonucleotides were provided by Gene-Tools, LLC. Additionally, various in vitro transcribed mRNAs were microinjected for overexpressing different proteins. Therefore, linearized plasmid DNA from MT-dnGCNF (linearized with Not1, transcribed with SP6; David et al., 1998) ; b-galactosidase (linearized with Pst1, transcribed with T3; Steinbeisser et al., 1995) . Noggin (linearized with Not1, transcribed with SP6; Smith and Harland, 1992) xRARa2 (linearized with EcoR1, transcribed with SP6; Sharpe, 1992) ; xRXRb (linearized with BamH1, transcribed with SP6, Sharpe and Goldstone, 1997); VP16 -mGCNF (linearized with Sfi1, transcribed with T7; Greschik et al., 1999) were used as template for in vitro transcription with the Message Machine Kit (from Ambion), following the manufacturer's instructions. The amounts of morpholino oligonucleotides and mRNAs were injected in 5-10 nl. After injection, embryos were transferred in to 0.1 £ MMR at stage 8 and incubated until the indicated stages at 14-23 8C.
All-trans retinoic acid (RA) and its antagonist citral (CI) were purchased from Sigma. Whole embryos were treated with 10 26 M RA, ectoderm explants with 10 27 M RA in the dark, from stage 9 until the stages indicated. CI treatment of whole embryos was performed with 6 £ 10 25 M CI from stage 10.5 until the stages indicated.
Western blotting
Protein extraction from embryos and Western blotting was carried out as described previously and affinitypurified antiserum against xEmGCNF [DEF] was used for xEmGCNF detection (David et al., 1998) . Nucleolin was detected using the monoclonal antibody b6-6E7 (Messmer and Dreyer, 1993) . A peroxidase linked goat anti mouse antibody (Dianova) was used as secondary antibody and was visualized using the chemiluminescence reagent Western Lightninge (Perkin Elmer Life Sciences, Inc.).
X-Gal staining and whole mount in situ hybridization
As a lineage tracer, 100-150 pg per blastomere of bgalactosidase mRNA were coinjected together with morpholino oligonucleotides or experimental mRNA. Injected embryos were cultured until the stages required, fixed in 1 £ MEMFA (100 mM MOPS pH 7.4; 2 mM EGTA and 1 mM MgSO 4 ) supplemented with 3.7% formaldehyde and processed for LacZ expression by an X-gal chromogenic reaction as previously described (Steinbeisser et al., 1989) , using 5-Brom-6-chlor-3-indolyl-b-D-galactopyranosid (Fluka) as substrate for b-gal to obtain a red color.
Whole mount in situ hybridization was performed essentially as described (Joos et al., 1996) , using digoxigenin-labeled antisense RNA probes specific of xEmGCNF (Joos et al., 1996) ; nerve specific tubulin (Good et al., 1989) ; XDelta-1 (Chitnis and Kintner, 1996) and xCYP26 (Hollemann et al., 1998) .
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was extracted from whole embryos or cultured animal caps with TriStare (ThermoHybaid) following the manufacturer's instruction. RT-PCR was performed using 0.5 mg total RNA as previously described (Niehrs et al., 1994) , except that SuperScripte II RNase H 2 Reverse Transcriptase (Gibco BRL) was used and PCR amplification was carried out using unlabeled nucleotides and Taq Polymerase from Amersham Pharmacia Biotech. PCR products were separated on 2% agarose gels in TAE buffer, stained with ethidiumbromide and visualized using a Kodak Image Station 440CF. The fluorescence signal of the specific bands was quantified by densitometry (using the program Kodak digital science 1D v3.0) and normalized relative to ODC. Gene-specific primer sets and PCR conditions are summarized in Table 1 . Although data from individual experiments are shown, the results were confirmed in multiple experiments in all cases.
NT-2 cells were cultured and treated with RA as previously described (Schmitz et al., 1999) . Cells of two 10 cm tissue culture dishes were pooled and homogenized using a Polytron homogenizer (Kinematica, Switzerland). Total RNA was isolated with application of an RNeasye Midi kit (Quiagen) following the instructions of the manufacturer. Approximately 1 mg of RNA was used for reverse transcription using RevertAide H Minus M-MuLV reverse transcriptase from MBI Fermentas.
Isolation of animal caps and cycloheximide treatment
Embryos were injected at the two-cell stage into both blastomeres. Animal cap explants from injected embryos were dissected in MMR at stage 8.5, transferred to 0.5 £ MMR in tissue culture plates coated with agar and either treated or non-treated with 10 27 M RA. The explants were cultured until the control embryos reached stage 17, except for the cycloheximide experiment. In this case the explanted animal caps were treated with 10 mg/ml cycloheximide (CHX, Sigma) for 2 h from stage equivalent 9.5 until 10.25 and harvested for RT-PCR immediately after finishing the CHX-treatment.
